This inventor holds 3 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: National Institute of Health and Medical Research, Pfizer Corporation, Université Cote D'azur. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 1,853 
2 out of 4,488 
2 out of 26 Years Active: 2019-2023
Title: Stéphanie Garcia: Innovator in Fibroblast Growth Factor Research
Introduction
Stéphanie Garcia is a notable inventor based in Nice, France. She has made significant contributions to the field of biomedical research, particularly in the area of fibroblast growth factors. With a total of 3 patents to her name, her work has the potential to impact the treatment of skeletal growth disorders.
Latest Patents
One of her latest patents is focused on soluble fibroblast growth factor receptor 3 (sFGFR3) polypeptides and their uses. This invention features methods for utilizing sFGFR3 polypeptides to treat skeletal growth retardation disorders, such as achondroplasia. The implications of this research are profound, as it addresses critical health issues related to skeletal development.
Career Highlights
Throughout her career, Stéphanie has worked with prestigious organizations, including the National Institute of Health and Medical Research and Pfizer Corporation. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific advancements.
Collaborations
Stéphanie has collaborated with various professionals in her field, including her coworker Elvire Gouze. Their joint efforts have furthered the understanding and application of fibroblast growth factors in medical treatments.
Conclusion
Stéphanie Garcia's innovative work in fibroblast growth factor research exemplifies the impact of dedicated inventors in the medical field. Her patents and collaborations highlight her commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile